Hidetaka Mochizuki
Overview
Explore the profile of Hidetaka Mochizuki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
3155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mochizuki H, Hirata H, Yoshihara T, Kobayashi T, Tsukamoto M, Uemura T, et al.
Clin Case Rep
. 2024 Dec;
12(12):e9701.
PMID: 39698005
Morel-Lavallée lesion (MLL) is a closed soft tissue injury following trauma that is often missed. If not treated appropriately, they can lead to infection and is difficult to treat. High-energy...
2.
Mochizuki H, Tsukamoto M, Morimoto T, Hirata H, Yoshihara T, Mawatari M
Spine J
. 2024 Apr;
24(5):909-910.
PMID: 38670782
No abstract available.
3.
Hidaka R, Matsuda K, Mochizuki H, Kawano H
Int J Med Robot
. 2023 Dec;
:e2613.
PMID: 38108101
Background: The aim of this study is to determine whether the initial stability of a cementless cup with the Mako system is superior to that of a conventional manual technique...
4.
Takayama T, Aramaki O, Shibata T, Oka M, Itamoto T, Shimada M, et al.
Surg Today
. 2019 Apr;
49(10):859-869.
PMID: 31030266
Purposes: This study compared the effectiveness of 1-day vs 3-days antibiotic regimen to prevent surgical site infection (SSI) in open liver resection. Method: We performed a randomized controlled non-inferiority trial...
5.
Matsuda C, Ishiguro M, Teramukai S, Kajiwara Y, Fujii S, Kinugasa Y, et al.
Eur J Cancer
. 2018 Apr;
96:54-63.
PMID: 29677641
Background: Efficacy of adjuvant chemotherapy in patients with stage II colon cancer is still controversial. The SACURA trial is a randomised-controlled study evaluating the superiority of 1-year adjuvant treatment with...
6.
Kawachi H, Eishi Y, Ueno H, Nemoto T, Fujimori T, Iwashita A, et al.
Mod Pathol
. 2015 Feb;
28(6):872-9.
PMID: 25720321
More than 85% of patients with T1 colorectal cancer have no lymph node metastasis and can be cured by endoscopic resection. To avoid unnecessary surgery after complete endoscopic resection, accurate...
7.
Kumagai K, Yamamoto N, Miyashiro I, Tomita Y, Katai H, Kushima R, et al.
Gastric Cancer
. 2013 Jun;
17(2):273-80.
PMID: 23743877
Background: The accurate diagnosis of lymph node (LN) metastasis is important for making treatment decisions for gastric cancer patients. This multicenter study evaluated the clinical performance of the one-step nucleic...
8.
Takatsuno Y, Mimori K, Yamamoto K, Sato T, Niida A, Inoue H, et al.
Ann Surg Oncol
. 2012 Sep;
20(4):1395-402.
PMID: 22976378
Background: The oncogenic single nucleotide polymorphism rs6983267, located on 8q24.21, may affect copy number aberrations and/or expression profiles in colorectal cancer (CRC). We investigated the role of this single nucleotide...
9.
Ishiguro M, Mochizuki H, Tomita N, Shimada Y, Takahashi K, Kotake K, et al.
BMC Cancer
. 2012 Jul;
12:281.
PMID: 22769569
Background: Adjuvant chemotherapy for stage III colon cancer is internationally accepted as standard treatment with established efficacy, but the usefulness of adjuvant chemotherapy for stage II colon cancer remains controversial....
10.
Takahashi Y, Mimori K, Yamamoto K, Watanabe M, Tanaka J, Kudo S, et al.
J Gastroenterol Hepatol
. 2012 Apr;
27 Suppl 3:95-9.
PMID: 22486879
Background And Aim: The incidence of both diabetes mellitus and hyperlipidemia is increasing and they are risk factors for colorectal cancer (CRC). On the other hand, the carcinogenic significance of...